In a year that saw a significant rise in the clinical pipeline of cannabis-derived therapeutics and the worldwide sales of Epidiolex soar, the 3rd International Cannabinoid Derived Pharmaceuticals Summit is back to facilitate continued growth in this sector and set the tone for the next year of forecasted groundbreaking research.
With over 20+ hours of content, 2 streams, a workshop day featuring 4 interactive sessions, poster session and 5+ hours of networking, you can join the only platform discussing issues present in the development and commercialization of pharmaceuticals with cannabinoids as an API.
Join this critical global forum which will again be uniting industry specialists from pharma, biotechs, academia and solution providers as we target the most pressing issues important to bringing the next generation of CDPs to market.
With over 20+ hours of content, 2 streams, a workshop day featuring 4 interactive sessions, poster session and 5+ hours of networking, you can join the only platform discussing issues present in the development and commercialization of pharmaceuticals with cannabinoids as an API.
Join this critical global forum which will again be uniting industry specialists from pharma, biotechs, academia and solution providers as we target the most pressing issues important to bringing the next generation of CDPs to market.
